Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.620
+0.060 (3.85%)
At close: Jun 27, 2025, 4:00 PM
1.622
+0.002 (0.10%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $2.42 million as of June 27, 2025. Its market cap has increased by 77.32% in one year.
Market Cap
2.42M
Enterprise Value
-495.77K
1-Year Change
77.32%
Ranking
Category
Stock Price
$1.62
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $2.42M, a decrease of -96.41%. That is a compound annual growth rate of -60.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 2.42M | -10.04% |
| Dec 31, 2024 | 2.69M | 78.03% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |